ArticleDiabetology & metabolic syndrome2025
Exploring inflammation and adipose tissue dysfunction in metabolically healthy versus unhealthy obesity among Arab adults.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Sex differences in insulin resistance and associated metabolic and inflammatory markers among adults with and without HIV in Zambia.Physiological reports · 2026Article
- Recent Insights Into Circulating Adipokines in Obesity: Systematic Review and Meta-Analysis.Obesity science & practice · 2026Review
- Risk factors for type 2 diabetes mellitus among university students in Saudi Arabia: a multi-regional cross-sectional study.Frontiers in endocrinology · 2026Observational
- Metabolic Multimorbidity and Risk of All-Cause and Cause-Specific Mortality: A Retrospective Cohort Study of 123,791 Chinese Adults.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Article
- Adipokine profiles and genetic variants of leptin receptor, adiponectin, and ghrelin pathways in obesity: prospective 12-month outcomes after bariatric interventions.Frontiers in endocrinology · 2026Observational
- Beyond the BMI Paradox: Unraveling the Cellular and Molecular Determinants of Metabolic Health in Obesity.Biomolecules · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundObesity is a heterogeneous condition. While Metabolically Healthy Obesity (MHO) is often considered to carry a lower risk of metabolic complications than Metabolically Unhealthy Obesity (MUO), findings on their differences remain inconsistent. This study examines for the first time the metabolic differences across obesity phenotypes in Saudi adults, addressing a literature gap in understudied populations with high obesity prevalence. MATERIALS AND
methodsThis cross-sectional study included 450 Saudi adults classified as MHO, MUO, or metabolically healthy normal weight (MHNW) based on BMI (≥ 30 kg/m²) and the presence of ≥ 3 metabolic abnormalities per National Cholesterol Education Program (NCEP) criteria. Anthropometric, metabolic, and inflammatory parameters were assessed. Age- and sex-adjusted logistic regression analyses were used to compare phenotypes.
resultsMUO individuals showed significantly higher adiposity indices, insulin resistance (HOMA-IR), and inflammatory markers compared to MHO individuals (p-values < 0.001). MHO individuals also differed significantly from MHNW individuals. Adiponectin levels were comparable across groups; however, the Adiponectin/Leptin ratio (adpn/lep) was lowest in the MUO group, indicating adipose tissue dysfunction. MUO individuals had increased odds of elevated HOMA-IR (OR = 5.76, p < 0.001) and CRP (OR = 2.64, p = 0.005) compared to MHO. While insulin resistance did not differ significantly between MHO and MHNW, MHO participants had higher odds of a low adpn/lep ratio (OR = 2.87, p < 0.005).
conclusionMUO individuals exhibited greater metabolic risk than MHO, with marked insulin resistance and inflammation. However, the presence of adipokine imbalance and elevated inflammatory markers in MHO suggests that ‘metabolic health’ in obesity may be relative rather than absolute.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.